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Abstract : β-lactam antibiotics are proconvulsive. In laboratory animals, this effect appears to be predominantly 
mediated through inhibition of GABA-A receptors, but it has not been demonstrated in humans in vivo. We report 
images of a [11C]Ro15-4513 PET from a 40 years old male who had completed a one week course of flucloxacillin 
before it. Relative to healthy controls, the participant had significantly lower mean grey matter binding. These 
novel data suggest that in humans, the proconvulsive effect of β-lactam antibiotics is mediated via either 























































FIGURE 1. β-lactam antibiotics such as flucloxacillin are proconvulsive, and seizures are a well-recognized 
manifestation of penicillin neurotoxicity[1,2]. In laboratory animals, this effect appears to be predominantly 
mediated through inhibition of GABA-A receptors[3–5]. However, to our knowledge, the effect of β-lactam 
antibiotics on GABA-A receptor binding has not been demonstrated in humans in vivo.  
[11C]Ro15-4513 was used to acquire positron emission (PET) data from a 40-year-old male who had 
completed a one-week course of flucloxacillin 250mg q.i.d. one day before the scan. Data were acquired as 
described previously[6]. [11C]Ro15-4513 volume-of-distribution (VT; i.e. binding) reflects the availability of GABA-
A receptor subunit: total, α1 (mostly fast), and α5 (mostly slow) components [7] . We corrected for partial volume 
effects s using SFS- RR[8]. 
Relative to 23 unmedicated healthy controls, the participant had significantly lower mean grey matter 
total VT (-30% [3.39 vs. mean ± standard deviation 4.86 ± 0.51], p=0.002). The reduction was of similar magnitude 
for both fast and slow mean grey matter VTs (fast: -29% [2.10 vs. 2.94 ± 0.29], p=0.002; slow: -31% [1.24 vs. 1.81 
± 0.60], p=0.174).  
The participant’s injectate had contained 17.05 g of ligand, whereas  3.44 ± 1.34 µg was typical for the 
healthy controls. This cannot explain our findings, as α5 subunit occupancy was ~11.9%, and α1 occupancy only 
~1.0%, with a near-identical reduction for both components. 
These novel data suggest that in humans, the proconvulsive effect of β-lactam antibiotics is mediated 
via either competition for the same benzodiazepine binding site as [11C]Ro15-4513, or downregulation of GABA-
A receptor expression.  
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